UK markets closed

Mitek Systems, Inc. (MITK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
13.58+0.49 (+3.74%)
As of 12:32PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 612.02M
Enterprise value 629.96M
Trailing P/E 62.47
Forward P/E 13.62
PEG ratio (5-yr expected) 1.28
Price/sales (ttm)3.72
Price/book (mrq)2.86
Enterprise value/revenue 3.85
Enterprise value/EBITDA 26.66

Trading information

Stock price history

Beta (5Y monthly) 1.11
52-week change 345.61%
S&P500 52-week change 322.43%
52-week high 316.24
52-week low 38.96
50-day moving average 312.73
200-day moving average 311.79

Share statistics

Avg vol (3-month) 3537.43k
Avg vol (10-day) 3602.61k
Shares outstanding 546.79M
Implied shares outstanding 646.79M
Float 842.19M
% held by insiders 12.45%
% held by institutions 178.63%
Shares short (15 Apr 2024) 44.17M
Short ratio (15 Apr 2024) 46.79
Short % of float (15 Apr 2024) 49.10%
Short % of shares outstanding (15 Apr 2024) 48.91%
Shares short (prior month 15 Mar 2024) 43.16M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -1.52%
Operating margin (ttm)-16.61%

Management effectiveness

Return on assets (ttm)0.67%
Return on equity (ttm)-1.23%

Income statement

Revenue (ttm)163.77M
Revenue per share (ttm)3.57
Quarterly revenue growth (yoy)-19.20%
Gross profit (ttm)N/A
EBITDA 21.64M
Net income avi to common (ttm)-2.49M
Diluted EPS (ttm)-0.06
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.91M
Total cash per share (mrq)2.65
Total debt (mrq)143.85M
Total debt/equity (mrq)67.28%
Current ratio (mrq)4.70
Book value per share (mrq)4.59

Cash flow statement

Operating cash flow (ttm)16.86M
Levered free cash flow (ttm)7.4M